Thousands of women could be spared chemo for breast cancer without reducing the odds of survival

THOUSANDS of women with breast cancer could avoid chemotherapy without risking their survival chances thanks to a new gene test. The Prosigna check uses a biopsy or tumour sample after surgery to work out how aggressive the genes driving a cancer’s growth are. In a study led by University College London, patients with a low...